As such, interference with the HCV NS3/4A functions should lead to inhibition of the viral replication as well as restoration of the virally suppressed host innate immune response and might as well reduce the hepatocellular carcinoma incidence among the chronically infected subjects. This evidence concerns the gene KRAS and hepatocellular carcinoma.